Tanska - tanska - Lægemiddelstyrelsen (Danish Medicines Agency)

bayer ab - drospirenon, ethinylestradiol - filmovertrukne tabletter - 3 mg+0,02 mg

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - drospirenonum, ethinylestradiolum - compresse rivestite con film - i) wirkstoffhaltige tablette: drospirenonum 3.000 mg, ethinylestradiolum 0.020 mg ut ethinylestradiolum et betadexum, lactosum monohydricum 48.180 mg, maydis amylum, magnesii stearas, Überzug: hypromellosum, talcum, e 171, e 172 (rubrum), pro compresso obducto. ii) placebotablette: cellulosum microcristallinum, lactosum monohydricum 23.205 mg, magnesii stearas, Überzug: hypromellosum, talcum, e 171, pro compresso obducto. - ormonale contraccettivo - synthetika

Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - drospirenonum, ethinylestradiolum - comprimés pelliculés - i) wirkstoffhaltige tablette: drospirenonum 3.000 mg, ethinylestradiolum 0.020 mg ut ethinylestradiolum et betadexum, lactosum monohydricum 48.180 mg, maydis amylum, magnesii stearas, Überzug: hypromellosum, talcum, e 171, e 172 (rubrum), pro compresso obducto. ii) placebotablette: cellulosum microcristallinum, lactosum monohydricum 23.205 mg, magnesii stearas, Überzug: hypromellosum, talcum, e 171, pro compresso obducto. - la contraception hormonales - synthetika

Yhdysvallat - englanti - NLM (National Library of Medicine)

glaxosmithkline llc - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

Yhdysvallat - englanti - NLM (National Library of Medicine)

mckesson rxpak inc - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

Latvia - latvia - Zāļu valsts aģentūra

bayer ag, germany - ethinylestradiolum, drospirenonum - apvalkotā tablete - 0,02 mg/3 mg

Viro - viro - Ravimiamet

bayer ag - drospirenoon+etünüülöstradiool - õhukese polümeerikattega tablett - 0+0/3mg+0,02mg 52tk / 312tk; 0+0/3mg+0,02mg 12tk / 72tk; 0+0/3mg+0,02mg 4tk / 24tk

Norja - norja - Statens legemiddelverk

bayer ab - solna - etinyløstradiolbetadeksklatrat / drospirenon - tablett, filmdrasjert - 0.02 mg / 3 mg

Ruotsi - ruotsi - Läkemedelsverket (Medical Products Agency)

bayer ab - drospirenon; etinylestradiol betadex - filmdragerad tablett - 0,02 mg/3 mg - etinylestradiol betadex 173,17 mikrog aktiv substans; drospirenon 3 mg aktiv substans; laktosmonohydrat hjälpämne; laktosmonohydrat hjälpämne - drospirenon och etinylestradiol

Kreikka - kreikka - Εθνικός Οργανισμός Φαρμάκων

bayer ΕΛΛΑΣ ΑΒΕΕ - drospirenone and estrogen - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - (0,020+3,000)mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ